Achalasia

Dilation, injection or surgery?

Alberto Peracchia, Luigi Bonavina

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Achalasia results from irreversible alterations of the esophageal myenteric plexus. The target of treatment in this setting is to reduce lower esophageal sphincter resistance to passage of the bolus. Definitive treatment of the disease requires pneumatic dilation or Heller myotomy. Although no controlled studies comparing modern endoscopic and surgical techniques are available, laparoscopic surgery is emerging as the initial intervention of choice.

Original languageEnglish
Pages (from-to)441-443
Number of pages3
JournalCanadian Journal of Gastroenterology
Volume14
Issue number5
Publication statusPublished - May 2000

Fingerprint

Esophageal Achalasia
Dilatation
Myenteric Plexus
Lower Esophageal Sphincter
Injections
Laparoscopy
Therapeutics

Keywords

  • Achalasia
  • Botulinum toxin
  • Fundoplication
  • Lower esophageal sphincter
  • Myotomy
  • Pneumatic dilation

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Achalasia : Dilation, injection or surgery? / Peracchia, Alberto; Bonavina, Luigi.

In: Canadian Journal of Gastroenterology, Vol. 14, No. 5, 05.2000, p. 441-443.

Research output: Contribution to journalArticle

Peracchia, Alberto ; Bonavina, Luigi. / Achalasia : Dilation, injection or surgery?. In: Canadian Journal of Gastroenterology. 2000 ; Vol. 14, No. 5. pp. 441-443.
@article{a6a38e2fabd34f5e8147205b57ef92a6,
title = "Achalasia: Dilation, injection or surgery?",
abstract = "Achalasia results from irreversible alterations of the esophageal myenteric plexus. The target of treatment in this setting is to reduce lower esophageal sphincter resistance to passage of the bolus. Definitive treatment of the disease requires pneumatic dilation or Heller myotomy. Although no controlled studies comparing modern endoscopic and surgical techniques are available, laparoscopic surgery is emerging as the initial intervention of choice.",
keywords = "Achalasia, Botulinum toxin, Fundoplication, Lower esophageal sphincter, Myotomy, Pneumatic dilation",
author = "Alberto Peracchia and Luigi Bonavina",
year = "2000",
month = "5",
language = "English",
volume = "14",
pages = "441--443",
journal = "Canadian Journal of Gastroenterology",
issn = "0835-7900",
publisher = "Pulsus Group Inc.",
number = "5",

}

TY - JOUR

T1 - Achalasia

T2 - Dilation, injection or surgery?

AU - Peracchia, Alberto

AU - Bonavina, Luigi

PY - 2000/5

Y1 - 2000/5

N2 - Achalasia results from irreversible alterations of the esophageal myenteric plexus. The target of treatment in this setting is to reduce lower esophageal sphincter resistance to passage of the bolus. Definitive treatment of the disease requires pneumatic dilation or Heller myotomy. Although no controlled studies comparing modern endoscopic and surgical techniques are available, laparoscopic surgery is emerging as the initial intervention of choice.

AB - Achalasia results from irreversible alterations of the esophageal myenteric plexus. The target of treatment in this setting is to reduce lower esophageal sphincter resistance to passage of the bolus. Definitive treatment of the disease requires pneumatic dilation or Heller myotomy. Although no controlled studies comparing modern endoscopic and surgical techniques are available, laparoscopic surgery is emerging as the initial intervention of choice.

KW - Achalasia

KW - Botulinum toxin

KW - Fundoplication

KW - Lower esophageal sphincter

KW - Myotomy

KW - Pneumatic dilation

UR - http://www.scopus.com/inward/record.url?scp=0034094914&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034094914&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 441

EP - 443

JO - Canadian Journal of Gastroenterology

JF - Canadian Journal of Gastroenterology

SN - 0835-7900

IS - 5

ER -